Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2025
Predicting Pathologic ≥N2 Disease in Women With Breast Cancer, Kerollos Nashat Wanis, Wenli Dong, Yu Shen, et al.
Implications of Omitting Sentinel Lymph Node Biopsy on Adjuvant Decision Making for Patients With Small Breast Cancers, Kerollos Nashat Wanis, Melissa P Mitchell, Sharon H Giordano, et al.
Improved Overall Survival in an Anti-Pd-L1 Treated Cohort of Newly Diagnosed Glioblastoma Patients Is Associated With Distinct Immune, Mutation, and Gut Microbiome Features: A Single Arm Prospective Phase I/II Trial, Shiao-Pei Weathers, Xiqi Li, Haifeng Zhu, et al.
The Late Positive Potential Predicts Contingency Management Outcomes for Cocaine Use Disorder, Heather E Webber, Douglas J Calvillo, Francesco Versace, et al.
Symptom Burden, Healthcare Utilization, and Risky Behaviors in Survivors of the Childhood Cancer Survivor Study (CCSS): An Observation Cohort Study, Rachel Webster, Deo Kumar Srivastava, Lu Xie, et al.
Prognostic Value of Serum and Bronchoalveolar Lavage Fluid Galactomannan Levels in Invasive Aspergillosis: An 8-Year Experience at a Tertiary Cancer Center, Saliba Wehbe, Anne-Marie Chaftari, Ray Hachem, et al.
Pediatric vs Adult Invasive Aspergillosis in Cancer and Hematopoietic Transplant Patients: Insights from a Matched Cohort at a Tertiary Cancer Center, Saliba Wehbe, Ramia Zakhour, Ray Hachem, et al.
CAR-Macrophage Cell Therapy: A New Era of Hope for Pancreatic Cancer, Daoyan Wei, Liang Wang, Yi Liu, et al.
Safety and Efficacy of DTX401, an AAV8-Mediated Liver-Directed Gene Therapy, in Adults With Glycogen Storage Disease Type I a (GSDIa), David A Weinstein, Terry G Derks, David F Rodriguez-Buritica, et al.
Genetic Determinants and Genomic Consequences of Non-Leukemogenic Somatic Point Mutations, Joshua S Weinstock, Sharjeel A Chaudhry, Maria Ioannou, et al.
Concurrent Bone Marrow Acute Undifferentiated Leukemia and Mediastinal T‐Lymphoblastic Lymphoma With Identical SET::NUP214 Fusion and PHF6 and EZH2 Mutations, Qing Wei, Fatima Z Jelloul, Sa A Wang, et al.
Acute Myeloid Leukemia With t(10; 17)(p15; q21)/ ZMYND11::MBTD1: A Subtype With Minimal Differentiation, CD7/CD56 Expression, and Generally Poor Outcomes in Adults, Qing Wei, Naveen Pemmaraju, Sa A Wang, et al.
Cryptic KMT2A::AFDN Fusion Due to AFDN Insertion into KMT2A in a Patient with Acute Monoblastic Leukemia, Qing Wei, Gokce A Toruner, Beenu Thakral, et al.
Cryptic KMT2A::AFDN Fusion Due to AFDN Insertion into KMT2A in a Patient with Acute Monoblastic Leukemia, Qing Wei, Gokce A Toruner, Beenu Thakral, et al.
KRAS Inhibition Activates an Actionable CD24 "Do Not Eat Me" Signal in Pancreatic Cancer, Yongkun Wei, Minghui Liu, Er-Yen Yen, et al.
Gain-of-Function Chromatin Remodeling Activity of Oncogenic FOXL2C134W Reprograms Glucocorticoid Receptor Occupancy to Drive Granulosa Cell Tumors, Thomas Welte, Veena K Vuttaradhi, Eleonora Y Khlebus, et al.
Dose Planning and Radiation Optimization for Thoracic Conventional, Twice Daily, and Stereotactic Radiation Therapy: A Delphi Consensus From a National Survey of Practitioners, Julius Weng, Jeff Ryckman, Matthew S Katz, et al.
CD177+ Neutrophils: New Drivers of Liver Regeneration, Yankai Wen and Cynthia Ju
Author Correction: Autologous T cell therapy for PRAME+ Advanced Solid Tumors in HLA-A*02+ Patients: A Phase 1 Trial, Martin Wermke, Dejka M Araujo, Manik Chatterjee, et al.
Autologous T cell therapy for PRAME, Martin Wermke, Dejka M Araujo, Manik Chatterjee, et al.
Tumoral and Circulating Genomic Landscape Inform Survival Differences in Colorectal Carcinomatosis, Michael G White, Reed I Ayabe, Mohammad A Zeineddine, et al.
Long-Term Cytoreduction Outcomes With or Without Heated Intraperitoneal Chemotherapy For Colorectal Peritoneal Metastases, Michael G White, Paula Marincola Smith, Neal Bhutiani, et al.
The Landscape of ctDNA in Appendiceal Adenocarcinoma, Michael G White, Mohammad A Zeineddine, Eleanor A Fallon, et al.
Zongertinib (BI 1810631), an Irreversible HER2 TKI, Spares EGFR Signaling and Improves Therapeutic Response in Preclinical Models and Patients with HER2-Driven Cancers, Birgit Wilding, Lydia Woelflingseder, Anke Baum, et al.
Reduced Venetoclax Exposure to 7 Days vs Standard Exposure With Hypomethylating Agents in Newly Diagnosed Aml Patients, Christophe Willekens, Alexandre Bazinet, Samy Chraibi, et al.